United States · FDA National Drug Code directory
Valsartan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72336-910_dd4cbd3f-572e-400b-8fe7-98d537557b80
- Product NDC
- 72336-910
- Form
- SOLUTION
- Composition / generic term
- Valsartan
- Labeler
- Lifsa Drugs LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220404
- Source listing expiry
- 20261231
Source-listed ingredients
- VALSARTAN — 4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 120 mL in 1 BOTTLE, PLASTIC (72336-910-79) · 72336-910-79
- 473 mL in 1 BOTTLE, PLASTIC (72336-910-89) · 72336-910-89
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →